QuintilesIMS to Announce Fourth Quarter 2016 Results

and Issue 2017 Guidance on February 14, 2017

January 31, 2017

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C. – January 31, 2017 – Quintiles IMS Holdings, Inc. (“QuintilesIMS”) (NYSE:Q) will announce its fourth-quarter and full-year 2016 financial results and issue 2017 guidance before the market opens on Tuesday, February 14, 2017. The QuintilesIMS management team will host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the QuintilesIMS Investor Relations website at http://ir.quintilesims.com.

Interested parties are invited to listen to the live event and view the presentation slides via webcast on the QuintilesIMS Investor Relations website at http://ir.quintilesims.com. The discussion also will be available by dialing +1-800-616-7436 in the U.S. and Canada, or +1-303-223-4394 for international callers.

A replay of the webcast will be available approximately two hours after the conclusion of the live event on February 14. To access the webcast recording, visit http://ir.quintilesims.com.

About QuintilesIMS

QuintilesIMS (NYSE:Q) is a leading integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles Transnational and IMS Health, QuintilesIMS’s approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes through treatment innovations, care provision and access can leverage QuintilesIMS’s broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS provides solutions that span clinical to commercial, bringing customers a unique opportunity to realize the full potential of innovations and advanced healthcare outcomes.

As a global leader in protecting individual patient privacy, QuintilesIMS uses healthcare data to deliver critical, real-world disease and treatment insights. Through a wide variety of privacy-enhancing technologies and safeguards, QuintilesIMS protects individual privacy while managing information to drive healthcare forward. These insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders in the development and approval of new therapies, and to identify unmet treatment needs and understand the safety, effectiveness and value of pharmaceutical products in improving overall health outcomes. To learn more, visit www.QuintilesIMS.com.